Ask AI
ProCE Banner Activity

Mastering the Evolving Treatment Paradigm in SCLC: Immunotherapy Transforming Care for LS-SCLC

Slideset

Download these slides to gain expert insight into the current treatment paradigm and incorporating immunotherapy into personalized treatment plans for patients with limited-stage small-cell lung cancer.

Released: May 30, 2025

Expiration: November 29, 2025

Continue Activity

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Amgen, Daiichi Sankyo, Inc., Jazz Pharmaceuticals, Inc. and Merck Sharp & Dohme LLC.

Amgen

Daiichi Sankyo, Inc.

Jazz Pharmaceuticals, Inc.

Merck Sharp & Dohme, LLC